Monash University and Dotz will partner in R&D of new bio-imaging technologies
Dotz Nano Ltd. is pleased to announce that a collaboration agreement was signed today with Monash University of Melbourne, Australia.
As a part of this agreement, Dotz and Monash will collaborate to develop and commercialise advanced multi-purpose carbon-based materials as next-generation bio-imaging agents for various research and preclinical uses such as cancer tracing. Due to their unique properties and low toxicity, this family of advanced carbon materials holds great potential to compete and replace expensive and toxic quantum dots currently in use in this field.
Both parties have declared their interest in a joint-venture that will be dedicated to the development and commercialisation of such applications.
“As part of our on-going efforts to enhance our offering of ‘Made in Australia’ developments, we are excited to join hands with Monash University, a prominent Australian establishment” says Uzi Breier, Dotz’s CEO. “This is an excellent example where a technology leader, with ground-breaking innovation, is teaming up with a leading academic institution to create a bridge between academia and the business-world. I’m sure that our joint-venture will create new and exciting novelties in bioimaging”.
Prof. Nicolas Voelcker, Professor at the Monash Institute of Pharmaceutical Sciences (MIPS) and Director of the Melbourne Centre for Nanofabrication (MCN) and Dr Roey Elnathan (MIPS) added: “As the leading micro- and nanofabrication facility in Australia and headquarters of the Australian National Fabrication Facility (ANFF), we are proud to partner with Dotz. Their team of academic experts, combined with their business reach, is the perfect match to the MCN’s aspirations in supporting both academic excellence, enhancing collaboration between academia and industry and nurturing Australian business capabilities. One of our core strengths is in the medtech area and by combining this with Dotz’s proprietary technologies, we intend to spearhead the development of new applications for Dotz’s carbon-based nanomaterials in bio-imaging and bio-sensing.”
The bio-imaging Market
Bio-imaging aims to improve human health with the use of imaging techniques to advance diagnosis, prevention and treatment of human diseases. Medical imaging techniques such as molecular probes and bio-markers are becoming the leading diagnostic techniques for tumors and cancer cells.
The bio-imaging techniques are regarded as promising advancements in the field of healthcare and biomedical research. This multi-billion market has a tremendous potential to grow over the coming years as this technology may evolve as a pillar for diagnosis, which is expected to give rise to numerous innovations and business opportunities
Dotz is a technology leader in research, production and marketing of anti-counterfeiting, authentication and tracing solutions. Dotz has strong, established distributors in North America, Europe, Japan, China and Australia as well as Scientific Collaborations and Partnerships with leading academic institutes.
Its unique products, ValiDotz™, Fluorensic™, InSpec™ and BioDotz™ are exceptional solutions for numerous applications, such as: Anti-counterfeiting, Brand & Reputation Protection, Oil & Gas Industry, Liquids Tagging, Lubricants and DEF authentication, Polymers Tagging and Bio-Imaging.
Several parameters make Dotz a world leader in developing, manufacturing and marketing of high end ValiDotz™:
- Global Presence – With offices in Australia, China, the United States, United Kingdom and Israel,
- Long term Agreements – With strong, established distributors in North America, Europe, Japan, China and Australia, and
- Scientific Collaborations and Partnerships – With leading academic institutes.
About Monash University
Monash University is the largest university in Australia, ranked in the world’s top 100 and a member of the prestigious Group of Eight. We're named after Sir John Monash, and fuelled by his desire for our students to leave here with a greater sense of purpose, and the skills and confidence to create positive change.
In under 60 years, we’ve grown from a single campus into an education and research powerhouse with a presence on four continents, committed to the challenges of the age.
Our work is making an impact all over the world, from bringing clean water to villages in Africa to creating new life-saving medicines. With four Australian campuses, one in Malaysia, and over 100 international partners, we’re making a difference on a global scale.
About ANFF and MCN
The Australian National Fabrication Facility (ANFF) is a network organisation that has been established under the National Collaborative Research Infrastructure Strategy (NCRIS) in 2007. ANFF is comprised of 8 nodes offering service capabilities such as micro and nano fabrication, characterisation, device fabrication, packaging and testing. These nodes are supported by 21 Australian research institutions with world-class facilities, deep academic knowledge and technical know-how. The ANFF is well resourced to facilitate international collaboration and offer access to specialised equipment for product development. With continued investments by the Federal Education Infrastructure Fund and the State Governments of New South Wales, Queensland, Victoria and South Australia, ANFF is engaged with projects valued at over $200mil with local as well as international collaborators such as the US Air Force and NASA.
In addition, the ANFF seeks to bridge the translation gap between theoretical research and achieving commercial outcomes. Our goal is to ensure Australia’s continued economic success through the mentorship of engineers into entrepreneurs and nurturing of new ideas with strong societal and economic contributions.
The mission of the Victorian node of ANFF (ANFF-Vic) with its central facility the Melbourne Centre for Nanofabrication (MCN) and its allied hubs is to fill the gap in Australia for open access, multi-scale fabrication infrastructure, spanning a broad range of fabrication environments and materials with a focus in medtech. The node not only provides the means to produce complex micro- and nano-science based demonstration devices for academia and industry using an array of tools but will also provide expertise on and tools for high-throughput validation, upscaling of various systems including lithographies, nanofibre and textile production, thin films coatings and microceramics.
Contact: Divya Krishnan